Did you know?

  • The Centers for Disease Control and Prevention estimate that two million patients suffer hospital-acquired infections each year.
  • The majority of nosocomial infections, especially in intensive care units, are caused by catheter-related bloodstream infections (CRBSIs).
  • The estimated cost per infection in the ICU can be up to $56,000 per episode.
  • Despite the extraordinary hard work and best intentions of caregivers, patient outcomes can be improved in US hospital every day.

Explore how Bard Access Systems can help you better meet your patients’ needs through the Critical Choice™ program. In conjunction with Bard Access System’s Assessment Advantage® program, it assists health care professionals in determining the most appropriate venous access device early in the patient’s hospitalization based on diagnosis and drug therapy.

A proactive patient assessment program may result in fewer peripheral venous sticks, consistent delivery of IV therapy without interruptions, enhanced clinical outcomes, and patient satisfaction.

Program Objectives:

  • Identify patients who will need mid-term to long-term venous access devices within 24 hours of ICU admission.
  • Enhance clinical outcomes by providing uninterrupted IV therapy resulting in consistent timely drug delivery.
  • Increase patient satisfaction by decreasing the number of IV and venous sticks for blood draws.

How the Program Works:

  • If a patient meets indications listed on the Assessment Advantage® Program diagnosis, drug, or patient medical condition card, then a referral is made to the PICC/IV team by a physician, case manager or nurse for venous assessment.
  • Along with ICU staff, a PICC/IV team member will assess the patient for the appropriate venous access device and obtain a physician’s order if necessary, and then insert the device.
  • Once a venous access device is placed, the patient is monitored by the PICC/IV team and ICU staff to ensure quality outcomes.